Gerstel Group Changes Ownership
Holger R. Gerstel
Holger R. Gerstel, Co-Owner and General Manager of Gerstel (Mülheim an der Ruhr, Germany), has acquired all remaining shares of the company from his brother, Eberhard G. Gerstel, completing a change of ownership for the German company. The transaction sees the retirement of Eberhard Gerstel from all roles and functions within the company.
“The foundation has now been laid to transfer Gerstel to the third generation of the family. I would like to expressly thank my brother Eberhard for making this possible, and for our excellent relationship over more than two decades of highly successful cooperation,” said Holger Gerstel.
Founded in 1967 by the late Eberhard Gerstel (1927–2004), Gerstel has grown under the stewardship of his sons Eberhard and Holger, who assumed control in 1998, and who, alongside Ralf Bremer, have developed Gerstel into a respected provider of laboratory analysis solutions, particularly in automated sample preparation.
“We will continue to invest significant amounts in development and production, in our research and application laboratories, as well as in our customer support and training facilities, to broaden our offering while continuing to provide our customers [with] best-in-class support,” continued Holger.
For more information, please visit: www.gerstel.com
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.
